Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United Kingdom based CFO’ operating in the Life Science space. If you think a CFO’ is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Giovanni Pericolini
Finance Director & CFO of Medicxi Ventures
Follow Giovanni Pericolini:
About Medicxi Ventures: Medicxi is a life sciences-focused investment firm.
Karam Hirji
CFO of Polymateria
Karam Hirji is the Chief Financial Officer of Polymateria.
Follow Karam Hirji:
About Polymateria: Polymateria is a London-based startup advancing science to help nature deal with plastic pollution.
Zalakben Kataria
CFO & DIrector of CLYZ Labs
Zalakben holds a Bachelors in Business Administration from S.P. University in India. Zalakben has a number of years’ experience as a project manager in Clinical Finance Ltd. Prior to her work with Clinical Finance Ltd Zalakben was based in India
Follow Zalakben Kataria:
About CLYZ Labs: CLYZ Labs are developing a testing service to select the best drug therapy for personalised cancer treatment.
Zalakben Kataria
CFO & DIrector of CLYZ Labs
Zalakben holds a Bachelors in Business Administration from S.P. University in India. Zalakben has a number of years’ experience as a project manager in Clinical Finance Ltd. Prior to her work with Clinical Finance Ltd Zalakben was based in India
Follow Zalakben Kataria:
About CLYZ Labs: CLYZ Labs are developing a testing service to select the best drug therapy for personalised cancer treatment.
Michael Neame
Chief Financial Officer of Nature Metrics
Michael Neame is the Chief Financial Officer at Nature Metrics.
Follow Michael Neame:
About Nature Metrics: Nature Metrics is an award-winning technology start-up using cutting-edge genetic techniques to monitor biodiversity.
Jiahao Huang
Co-founder, Director and CFO of Nuclera
A molecular biologist by trade, Jiahao has coordinated multi-national collaborative projects and experienced first hand the limitations of the current provision of DNA. This intimate knowledge of user requirements enables him to guide Nuclera’s commercial operations towards creating the right product for the right market. Jiahao holds a BSc from the University of California, Berkeley, and a PhD in Molecular Biology from the University of Cambridge.
Follow Jiahao Huang:
About Nuclera: Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis.
Andy Boteler
CFO of Gooch & Housego
Follow Andy Boteler:
About Gooch & Housego: Gooch & Housego is a global leader in photonics technology.
Raymond Spencer
CFO of OxStem
Raymond Spencer, CFO has over 30 years’ experience as a senior financial officer in biotech. For 12 years he was the CFO of LSE listed Antisoma plc. Whilst at Antisoma he was instrumental in completing the IPO in 1998, several fund-raising rounds that totalled over £100 million, the acquisition of two private US biotech companies and the closing of three licensing deals with big pharma with total upfront licence fees exceeding £100m. Raymond was CFO for AIM listed Summit plc for 5 years to July 2014 having completed a restructuring of the company, raised over £20m in equity financing and the acquisition of the Oxford University spin-out MuOx Ltd. Raymond is currently part-time founder, Director and CFO of MGB-Biopharma Ltd, which has raised over £6m from angel investors, Scottish Enterprise and won a Biomedical Catalyst award from Innovate UK to progress drugs for treatment of anti-microbial resistance. He has also established his own consultancy company, Bio-CFO Ltd providing services to biotech and cleantech companies. Raymond qualified as a chartered accountant with KPMG in 1979.
Follow Raymond Spencer:
About MGB Biopharma, OxStem: OxStem is a drug discovery company.
